Neuronetics Narrows FY2026 Sales Guidance from $160.000M-$166.000M to $160.000M-$164.000M vs $161.125M Est
Neuronetics (NASDAQ: STIM ) narrows FY2026 sales outlook from $160.000 million-$166.000 million to $160.000 million-$164.000 million vs $161.125 million estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.